Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances at Dec. 31, 2019	$ 1,727	$ 95,032,252	$ (86,935,593)	$ 8,275,771
Balances (in Shares) at Dec. 31, 2019	17,270,848
Stock-based compensation	$ 15	629,978		629,993
Stock-based compensation (in Shares)	150,000
Issuance of common stock to settle accounts payable	$ 0	8,270		8,270
Issuance of common stock to settle accounts payable (in Shares)	3,540
Net loss			(7,298,869)	(7,298,869)
Foreign currency translation				(36,029)
Balances at Jun. 30, 2020	$ 1,822	97,581,422	(94,234,462)	3,490,138
Balances (in Shares) at Jun. 30, 2020	18,221,807
Modification of warrants issued with debt		95,223		95,223
Sale of common stock for cash	$ 11	199,989		200,000
Sale of common stock for cash (in Shares)	114,719
Warrant exercise	$ 68	1,248,915		1,248,983
Warrant exercise (in Shares)	682,700
Warrant exercise inducement		366,795		366,795
Balances at Mar. 31, 2020	$ 1,742	95,304,840	(90,772,014)	4,595,689
Balances (in Shares) at Mar. 31, 2020	17,424,388
Stock-based compensation		460,883		460,883
Net loss			(3,462,448)	(3,462,448)
Foreign currency translation				80,235
Balances at Jun. 30, 2020	$ 1,822	97,581,422	(94,234,462)	3,490,138
Balances (in Shares) at Jun. 30, 2020	18,221,807
Sale of common stock for cash	$ 11	199,989		200,000
Sale of common stock for cash (in Shares)	114,719
Warrant exercise	$ 68	1,248,915		1,248,983
Warrant exercise (in Shares)	682,700
Warrant exercise inducement		366,795		366,795
Balances at Dec. 31, 2020	$ 1,964	102,651,304	(98,234,151)	4,579,759
Balances (in Shares) at Dec. 31, 2020	19,642,519
Stock-based compensation		2,261,126		2,261,126
Settlement of accrued expense with stock options		349,376		349,376
Convertible notes converted to common stock	$ 117	6,232,223		6,232,340
Convertible notes converted to common stock (in Shares)	1,171,296
Cashless stock option exercise	$ 30	(30)
Cashless stock option exercise (in Shares)	286,453
Cashless warrant exercise	$ 26	(26)
Cashless warrant exercise (in Shares)	262,759
Net loss			(5,547,609)	(5,547,609)
Foreign currency translation				42,025
Balances at Jun. 30, 2021	$ 2,137	111,493,973	(103,781,760)	7,917,017
Balances (in Shares) at Jun. 30, 2021	21,363,027
Balances at Mar. 31, 2021	$ 2,012	103,401,916	(100,724,150)	2,880,776
Balances (in Shares) at Mar. 31, 2021	20,116,348
Stock-based compensation		1,634,546		1,634,546
Settlement of accrued expense with stock options		349,376		349,376
Convertible notes converted to common stock	$ 114	6,108,146		6,108,260
Convertible notes converted to common stock (in Shares)	1,138,346
Cashless stock option exercise	$ 11	(11)
Cashless stock option exercise (in Shares)	108,333
Net loss			(3,057,610)	(3,057,610)
Foreign currency translation				1,669
Balances at Jun. 30, 2021	$ 2,137	$ 111,493,973	$ (103,781,760)	$ 7,917,017
Balances (in Shares) at Jun. 30, 2021	21,363,027